https://www.prognyx.com/blog/astrazeneca-takes-2b-summit-stake-pairs-its-claudin-18-2-adc-with-ivonescimabPrognyxen2026-09-29AstraZeneca takes $2B Summit stake, pairs its Claudin 18.2 ADC with ivonescimab https://www.prognyx.com/blog/merck-and-daiichi-sankyo-withdraw-i-dxd-accelerated-approval-blaPrognyxen2026-09-28Merck and Daiichi Sankyo withdraw I-DXd accelerated-approval BLA